109 related articles for article (PubMed ID: 2018429)
1. [Abnormally high methotrexate levels in the cerebrospinal fluid after intravenous and intrathecal treatment for acute lymphoblastic leukemia].
Négre V; Leneveu A; Chevallier B; Roux A
Arch Fr Pediatr; 1991 Jan; 48(1):63. PubMed ID: 2018429
[No Abstract] [Full Text] [Related]
2. [Cerebrospinal fluid methotrexate level in children treated with medium-high and high doses of the drug].
Wysocki M; Balcar-Boroń A; Krzyzanowski M; Szadujkis-Szadurski L; Ozyński T; Nowaczyk-Michalak A
Acta Haematol Pol; 1992; 23(3):185-90. PubMed ID: 1492543
[TBL] [Abstract][Full Text] [Related]
3. Twelve years experience with methotrexate infusions in childhood ALL.
Moe PJ; Seip M; Wesenberg F; Kolmannskog S
An Esp Pediatr; 1988 Oct; 29 Suppl 34():54-8. PubMed ID: 3214038
[No Abstract] [Full Text] [Related]
4. Pharmacokinetics of methotrexate given intrathecally to children with acute lymphoblastic leukemia.
Skibińska L; Daszkiewicz P; Michalewska D; Radwańska U
Pol J Pharmacol Pharm; 1988; 40(2):135-43. PubMed ID: 3237563
[TBL] [Abstract][Full Text] [Related]
5. [Monitoring of methotrexate treatment of children with proliferative diseases of the hematopoietic system].
Bogusławska-Jaworska J; Orzechowska-Juzwenko K; Pejcz J; Wiela-Hojeńska A; Szczepaniak M; Erbel-Badeńska J
Pol Tyg Lek; 1988 Aug; 43(33):1053-6. PubMed ID: 3266666
[No Abstract] [Full Text] [Related]
6. Intrathecal methotrexate-induced acute cerebellar syndrome.
Ferhanoglu B; Ongören S; Ar CM; Uzel B; Forta H; Necioglu D
Ann Hematol; 2003 Apr; 82(4):241-3. PubMed ID: 12707728
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of methotrexate in children with acute lymphoblastic leukemia].
Lares-Asseff I; Paredes R; Taboada C; Cravioto J; Velázquez M; Roldán RM; Faisal AG
Bol Med Hosp Infant Mex; 1988 Oct; 45(10):671-80. PubMed ID: 3264171
[No Abstract] [Full Text] [Related]
8. Treatment of pediatric acute lymphoblastic leukemia.
Tucci F; Aricò M
Haematologica; 2008 Aug; 93(8):1124-8. PubMed ID: 18669975
[No Abstract] [Full Text] [Related]
9. Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.
Jönsson P; Höglund P; Wiebe T; Schrøder H; Seidel H; Skärby T
Anticancer Drugs; 2007 Sep; 18(8):941-8. PubMed ID: 17667600
[TBL] [Abstract][Full Text] [Related]
10. Delayed recognition of intrathecal methotrexate overdose.
Malbora B; Ozyurek E; Kocum AI; Ozbek N
J Pediatr Hematol Oncol; 2009 May; 31(5):352-4. PubMed ID: 19415018
[TBL] [Abstract][Full Text] [Related]
11. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
12. Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature.
Rolf N; Boehm H; Kaindl AM; Lauterbach I; Suttorp M
Klin Padiatr; 2006; 218(6):350-4. PubMed ID: 17080338
[TBL] [Abstract][Full Text] [Related]
13. [Burgdorf's reaction (painful acral erythema) in patients with acute lymphoblastic leukemia following medium-dose methotrexate therapy].
Wysocki M; Nowaczyk-Michalak A; Pilecki O; Kurylak A; Balcar-Boroń A; Trybuś L
Wiad Lek; 1992 Jun; 45(11-12):462-4. PubMed ID: 1441532
[TBL] [Abstract][Full Text] [Related]
14. [Unintentional intrathecal administration of a tenfold dose of methotrexate].
Kaczmarek M; Radwańska U
Acta Haematol Pol; 1990; 21(2):228-30. PubMed ID: 2131723
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid exchange after intrathecal methotrexate overdose. A report of two cases.
Jakobson AM; Kreuger A; Mortimer O; Henningsson S; Seidel H; Moe PJ
Acta Paediatr; 1992 Apr; 81(4):359-61. PubMed ID: 1606401
[TBL] [Abstract][Full Text] [Related]
16. Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
Widemann BC; Balis FM; Shalabi A; Boron M; O'Brien M; Cole DE; Jayaprakash N; Ivy P; Castle V; Muraszko K; Moertel CL; Trueworthy R; Hermann RC; Moussa A; Hinton S; Reaman G; Poplack D; Adamson PC
J Natl Cancer Inst; 2004 Oct; 96(20):1557-9. PubMed ID: 15494606
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.
Moe PJ; Holen A; Nygaard R; Glomstein A; Madsen B; Hellebostad M; Stokland T; Wefring KW; Steen-Johnsen J; Nielsen B; Hapnes C; Børsting S
Pediatr Hematol Oncol; 2003; 20(3):187-200. PubMed ID: 12637215
[TBL] [Abstract][Full Text] [Related]
18. Changes in plasma methionine and total homocysteine levels in patients receiving methotrexate infusions.
Broxson EH; Stork LC; Allen RH; Stabler SP; Kolhouse JF
Cancer Res; 1989 Nov; 49(21):5879-83. PubMed ID: 2790801
[TBL] [Abstract][Full Text] [Related]
19. Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia.
Escherich G; Göbel U; Jorch N; Spaar HJ; Janka-Schaub GE
Klin Padiatr; 2007; 219(3):134-8. PubMed ID: 17525906
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma multiforme following prophylactic cranial irradiation and intrathecal methotrexate in a child with acute lymphoblastic leukaemia : a case report.
Muzumdar DP; Desai K; Goel A
Neurol India; 1999 Jun; 47(2):142-4. PubMed ID: 10402343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
